At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Proof of Concept Study to Evaluate the Efficacy of an Occlusion Based Dentifrice in the Relief of Dentinal Hypersensitivity
In Brief
A Phase 2 clinical trial evaluating 5% calcium sodium phosphosilicate/ sodium monofluorophosphate dentifrice, 0% calcium sodium phosphosilicate/ sodium monofluorophosphate dentifrice, and 2 other interventions for Dentinal Hypersensitivity. Completed, enrolled 140 participants across 1 site.
Detailed Summary
The purpose of this exploratory study is to compare the treatment effect on dentinal hypersensitivity of a tubule occluding dentifrice as measured by Schiff and Tactile sensitivity. This proof of concept study will compare the test dentifrice with three other treatment groups.
Study Details
Timeline
Interventions
Calcium sodium phosphosilicate dentifrice (5% w/w) and 1500 ppm F as sodium monofluorophosphate
No calcium sodium phosphosilicate and 1500 ppm F as sodium monofluorophosphate
Sodium monofluorophospate dentifrice (1000 ppm F)
Dentifrice containing 1100ppm F as sodium fluoride